What is the key feature of the developed fibers?

They allow for arbitrary control of pore size up to 1,000nm while maintaining fiber strength, enabling selective adsorption of large-molecular-weight pathogenic substances.

What are the main applications?

They are aimed at being used as a new blood purification treatment option for intractable diseases such as autoimmune disorders and cancer.

AI News NQ Analysis

Creation of Porous Fibers for Adsorbing Pathogenic Substances in Intractable Diseases

NQ Score 51/100

AI Summary (NQ-processed)

Toray Industries has developed technology to control the pore size of PMMA porous fibers up to 1,000nm. This enables selective removal of large-molecular-weight pathogenic substances for intractable diseases. The company aims for early practical application in blood purification therapies.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the key feature of the developed fibers?: A: They allow for arbitrary control of pore size up to 1,000nm while maintaining fiber strength, enabling selective adsorption of large-molecular-weight pathogenic substances.
Q: What are the main applications?: A: They are aimed at being used as a new blood purification treatment option for intractable diseases such as autoimmune disorders and cancer.